Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
International Journal of Cancer|July 28, 2016
Serum NSE, MMP-9 and HER2 extracellular domain are associated with brain metastases in metastatic breast cancer patients: predictive biomarkers for brain metastases?Amélie Darlix, Pierre-Jean Lamy, Evelyne Lopez-Crapez, et al.
BMC Cancer|July 9, 2016
Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patientsAmélie Darlix, Pierre-Jean Lamy, Evelyne Lopez-Crapez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger womenCaroline Desmetz, Caroline Bascoul-Mollevi, Philippe Rochaix, et al.
The Journal of Molecular Diagnostics : JMD|May 9, 2015
Next-Generation Genotyping by Digital PCR to Detect and Quantify the BRAF V600E Mutation in Melanoma BiopsiesPierre-Jean Lamy, Florence Castan, Nicolas Lozano, et al.
Scientific Reports|October 31, 2018
Autologous cell lines from circulating colon cancer cells captured from sequential liquid biopsies as model to study therapy-driven tumor changesAlexandra Soler, Laure Cayrefourcq, Thibault Mazard, et al.
Annales De Biologie Clinique|October 12, 2013
[Evaluation of (-2)proPSA in combination with total PSA and free PSA for the early detection of prostate cancer]Pierre-Jean Lamy, Frédéric Montels, Diego Tosi, et al.
Bulletin Du Cancer|January 11, 2022
[Clinical use and evolution of circulating biomarkers in the era of personalized oncology: From protein markers to bioclinical scores]Alexandre Perrier, Pierre Hainaut, Pierre-Jean Lamy, et al.
Bulletin Du Cancer|January 17, 2022
[Moving towards a personalized oncology: The contribution of genomic techniques and artificial intelligence in the use of circulating tumor biomarkers]Alexandre Perrier, Pierre Hainaut, Alexandre Guenoun, et al.
Clinical and Translational Medicine|May 19, 2015
Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancerMounira El Demery, Gaiané Demirdjian-Sarkissian, Simon Thezenas, et al.
BMC Cancer|August 1, 2018
Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective studyMarie Viala, Akiko Chiba, Simon Thezenas, et al.
Pageof 9